カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/26 | 1,156 | 1,156 | 1,145 | 1,149 | -4 | -0.3% | 5,000 |
| 2024/02/22 | 1,150 | 1,155 | 1,144 | 1,153 | +11 | +1% | 5,800 |
| 2024/02/21 | 1,146 | 1,150 | 1,138 | 1,142 | -4 | -0.3% | 2,200 |
| 2024/02/20 | 1,144 | 1,155 | 1,144 | 1,146 | +2 | +0.2% | 2,400 |
| 2024/02/19 | 1,133 | 1,149 | 1,133 | 1,144 | +12 | +1.1% | 8,300 |
| 2024/02/16 | 1,128 | 1,132 | 1,118 | 1,132 | +10 | +0.9% | 5,100 |
| 2024/02/15 | 1,146 | 1,147 | 1,118 | 1,122 | -24 | -2.1% | 20,900 |
| 2024/02/14 | 1,143 | 1,157 | 1,143 | 1,146 | -7 | -0.6% | 5,400 |
| 2024/02/13 | 1,144 | 1,155 | 1,143 | 1,153 | +9 | +0.8% | 2,900 |
| 2024/02/09 | 1,152 | 1,157 | 1,144 | 1,144 | -8 | -0.7% | 5,700 |
| 2024/02/08 | 1,167 | 1,167 | 1,150 | 1,152 | -15 | -1.3% | 6,800 |
| 2024/02/07 | 1,165 | 1,169 | 1,160 | 1,167 | +1 | +0.1% | 9,000 |
| 2024/02/06 | 1,183 | 1,183 | 1,165 | 1,166 | -17 | -1.4% | 5,800 |
| 2024/02/05 | 1,181 | 1,192 | 1,176 | 1,183 | -10 | -0.8% | 4,700 |
| 2024/02/02 | 1,178 | 1,193 | 1,173 | 1,193 | +13 | +1.1% | 6,200 |
| 2024/02/01 | 1,177 | 1,185 | 1,175 | 1,180 | -13 | -1.1% | 6,900 |
| 2024/01/31 | 1,190 | 1,194 | 1,175 | 1,193 | +7 | +0.6% | 5,700 |
| 2024/01/30 | 1,198 | 1,198 | 1,184 | 1,186 | -20 | -1.7% | 5,000 |
| 2024/01/29 | 1,198 | 1,206 | 1,161 | 1,206 | +16 | +1.3% | 17,500 |
| 2024/01/26 | 1,230 | 1,230 | 1,172 | 1,190 | -35 | -2.9% | 30,800 |
| 2024/01/25 | 1,200 | 1,230 | 1,175 | 1,225 | +26 | +2.2% | 69,600 |
| 2024/01/24 | 1,161 | 1,199 | 1,161 | 1,199 | +34 | +2.9% | 10,000 |
| 2024/01/23 | 1,198 | 1,245 | 1,143 | 1,165 | -7 | -0.6% | 35,200 |
| 2024/01/22 | 1,229 | 1,229 | 1,156 | 1,172 | -58 | -4.7% | 31,800 |
| 2024/01/19 | 1,203 | 1,247 | 1,203 | 1,230 | +35 | +2.9% | 64,400 |
| 2024/01/18 | 1,157 | 1,196 | 1,156 | 1,195 | +39 | +3.4% | 21,400 |
| 2024/01/17 | 1,145 | 1,157 | 1,144 | 1,156 | +11 | +1% | 6,000 |
| 2024/01/16 | 1,127 | 1,158 | 1,127 | 1,145 | +24 | +2.1% | 19,700 |
| 2024/01/15 | 1,119 | 1,122 | 1,109 | 1,121 | +8 | +0.7% | 5,000 |
| 2024/01/12 | 1,108 | 1,119 | 1,093 | 1,113 | +9 | +0.8% | 11,300 |
| 2024/01/11 | 1,113 | 1,113 | 1,094 | 1,104 | -5 | -0.5% | 3,800 |
| 2024/01/10 | 1,110 | 1,117 | 1,092 | 1,109 | +5 | +0.5% | 5,400 |
| 2024/01/09 | 1,105 | 1,115 | 1,055 | 1,104 | -3 | -0.3% | 17,300 |
| 2024/01/05 | 1,104 | 1,119 | 1,104 | 1,107 | +3 | +0.3% | 8,700 |
| 2024/01/04 | 1,091 | 1,104 | 1,091 | 1,104 | +13 | +1.2% | 3,800 |
| 2023/12/29 | 1,110 | 1,114 | 1,090 | 1,091 | -7 | -0.6% | 5,500 |
| 2023/12/28 | 1,084 | 1,100 | 1,078 | 1,098 | +14 | +1.3% | 6,700 |
| 2023/12/27 | 1,086 | 1,121 | 1,083 | 1,084 | -7 | -0.6% | 22,200 |
| 2023/12/26 | 1,086 | 1,094 | 1,085 | 1,091 | +1 | +0.1% | 6,300 |
| 2023/12/25 | 1,095 | 1,095 | 1,085 | 1,090 | -5 | -0.5% | 2,800 |
| 2023/12/22 | 1,086 | 1,097 | 1,079 | 1,095 | +7 | +0.6% | 13,900 |
| 2023/12/21 | 1,098 | 1,098 | 1,083 | 1,088 | +1 | +0.1% | 22,300 |
| 2023/12/20 | 1,089 | 1,090 | 1,085 | 1,087 | -1 | -0.1% | 3,300 |
| 2023/12/19 | 1,099 | 1,099 | 1,088 | 1,088 | -12 | -1.1% | 3,200 |
| 2023/12/18 | 1,090 | 1,100 | 1,080 | 1,100 | +20 | +1.9% | 18,200 |
| 2023/12/15 | 1,079 | 1,087 | 1,072 | 1,080 | +1 | +0.1% | 2,100 |
| 2023/12/14 | 1,090 | 1,090 | 1,079 | 1,079 | -10 | -0.9% | 2,900 |
| 2023/12/13 | 1,093 | 1,093 | 1,085 | 1,089 | +4 | +0.4% | 1,500 |
| 2023/12/12 | 1,090 | 1,090 | 1,082 | 1,085 | +1 | +0.1% | 2,700 |
| 2023/12/11 | 1,100 | 1,100 | 1,083 | 1,084 | -6 | -0.6% | 8,200 |
51～
100
件表示中 / 3452件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 115,200円 | +6.8% | -13.8% | 2.78% | 8.83倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| サイフューズ | 72,700円 | +891.8% | - | 0.00% | - | 1.80倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
| キッズバイオ | 13,800円 | -4.5% | - | 0.00% | - | 6.02倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ソレイジア | 2,700円 | +102.6% | - | 0.00% | - | 2.62倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| メドレックス | 11,500円 | +1424.1% | - | 0.00% | - | 2.40倍 |
|
経皮吸収型製剤技術に強い創薬ベンチャー。治験は米国で。先端分野マイクロニードルに挑戦 |
市場注目の銘柄
チャート関連のコラム
